These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Experimental canine cholera. II. Production by cell-free culture filtrates of Vibrio cholerae. Sack RB; Carpenter CC J Infect Dis; 1969 Feb; 119(2):150-7. PubMed ID: 5776005 [No Abstract] [Full Text] [Related]
3. Protection of infant mice against cholera by antibodies to three antigens of Vibrio cholerae. Neoh SH; Rowley D J Infect Dis; 1972 Jul; 126(1):41-7. PubMed ID: 5038023 [No Abstract] [Full Text] [Related]
4. Significance of vibriocidal antibodies with regard to immunity to cholera. Gangarosa EJ; DeWitt WE; Feeley JC; Adams MR J Infect Dis; 1970 May; 121():Suppl 121:36+. PubMed ID: 4912071 [No Abstract] [Full Text] [Related]
5. Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes. Hochstein HD; Feeley JC; DeWitt WE Appl Microbiol; 1970 May; 19(5):742-5. PubMed ID: 5463574 [TBL] [Abstract][Full Text] [Related]
6. Experimental canine cholera. IV. The chronic carrier state for Vibrio cholerae. Sack RB; Carpenter CC; Yardley JH; Subong AE J Infect Dis; 1969 Feb; 119(2):165-71. PubMed ID: 5776007 [No Abstract] [Full Text] [Related]
7. Sensitivity of agglutinating and vibriocidal antibodies to 2-mercaptoethanol in human cholera. Merritt CB; Sack RB J Infect Dis; 1970 May; 121():Suppl 121:25+. PubMed ID: 4912070 [No Abstract] [Full Text] [Related]
9. Further studies on the cholera toxin and antitoxin. Ungar J; Stanić M; Varallyay SJ; Chariatte N Prog Immunobiol Stand; 1970; 4():583-9. PubMed ID: 4099025 [No Abstract] [Full Text] [Related]
10. [Studies of cholera cerisis inhibiting factor. 1. Isolation and specificity of the active substances from the small intestine of rabbits immunized with inactivated Vibrio cholerae]. Morimoto T; Yamamoto M; Maruyama S; Turumizu T; Matsui S Yakugaku Zasshi; 1971 Dec; 91(12):1354-61. PubMed ID: 5004220 [No Abstract] [Full Text] [Related]
11. Antitoxic immunity in experimental canine cholera. Curlin GT; Subong A; Craig JP; Carpenter CC Trans Assoc Am Physicians; 1968; 81():314-22. PubMed ID: 5721407 [No Abstract] [Full Text] [Related]
12. Experimental cholera in infant mice: protective effects of antibody. Chaicumpa W; Rowley D J Infect Dis; 1972 May; 125(5):480-5. PubMed ID: 5023642 [No Abstract] [Full Text] [Related]
14. Characteristics of the serum vibriocidal and agglutinating antibodies in cholera cases and in normal residents of the endemic and non-endemic cholera areas. Ahmed A; Bhattacharjee AK; Mosley WH J Immunol; 1970 Aug; 105(2):431-41. PubMed ID: 5433700 [No Abstract] [Full Text] [Related]
15. Experimental canine cholera. I. Development of the model. Sack RB; Carpenter CC J Infect Dis; 1969 Feb; 119(2):138-49. PubMed ID: 5776004 [No Abstract] [Full Text] [Related]
16. Magnitude and duration of antitoxic response to human infection with Vibrio cholerae. Pierce NF; Banwell JG; Sack RB; Mitra RC; Mondal A J Infect Dis; 1970 May; 121():Suppl 121:31+. PubMed ID: 5421427 [No Abstract] [Full Text] [Related]